Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.34 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.34 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | PGD | P52209 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15987193 | 1.00 | SLC22A6 (0.42) | SLC22A6SMN1; SMN2MAPTGABRR1LMNA | |
| SCHEMBL498582 | 0.83 | SLC22A6 (0.38) | SLC22A6SMN1; SMN2MAPTGABRR1LMNA | |
| SCHEMBL13424255 | 0.81 | SLC22A6 (0.42) | SLC22A6SMN1; SMN2MAPTGABRR1LMNA | |
| SCHEMBL28772970 | 0.79 | GABRP (0.38) | SLC22A6SMN1; SMN2GABRR1LMNATDP1 | |
| SCHEMBL2985404 | 0.77 | LMNA (0.40) | SLC22A6SMN1; SMN2MAPTGABRR1LMNA | |
| SCHEMBL22188543 | 0.77 | TDP1 (0.38) | TDP1 | |
| SCHEMBL4598341 | 0.77 | ALOX15 (0.47) | SLC22A6SMN1; SMN2MAPTGABRR1LMNA | |
| SCHEMBL20543906 | 0.77 | SLC22A6 (0.39) | SLC22A6SMN1; SMN2MAPTGABRR1LMNA | |
| SCHEMBL15987225 | 0.76 | ATM (0.34) | MAPTLMNA | |
| SCHEMBL17484893 | 0.76 | SLC22A6 (0.37) | SLC22A6SMN1; SMN2MAPTGABRR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160129679-A1 | METHOD FOR THE PRODUCTION OF A POLYCARBONATE LAMINATE | BUNDESDRUCKEREI GMBH (DE) | 2016-05-12 | — | — | US | claimed |
| EP-2205686-B1 | METHOD FOR THE PRODUCTION OF A POLYCARBONATE LAMINATE | BUNDESDRUCKEREI GMBH (DE) | 2011-03-16 | — | — | EP | claimed |
| US-20100301595-A1 | METHOD FOR THE PRODUCTION OF A POLYCARBONATE LAMINATE | BUNDESDRUCKEREI GMBH (DE) | 2010-12-02 | — | — | US | claimed |
| US-20220404703-A1 | SEMICONDUCTOR DEVICE AND IMPRINT METHOD | KIOXIA CORPORATION (JP) | 2022-12-22 | — | — | US | disclosed |
| US-20210324372-A1 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID ISOLATION | CEPHEID (US) | 2021-10-21 | — | — | US | disclosed |
| EP-3837363-A1 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID ISOLATION | Cepheid (US) | 2021-06-23 | — | — | EP | disclosed |
| US-10723109-B2 | Method for producing a polycarbonate layered composite | COVESTRO DEUTSCHLAND AG (DE) | 2020-07-28 | — | — | US | disclosed |
| WO-2020037260-A1 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID ISOLATION | CEPHEID (US) | 2020-02-20 | — | — | WO | disclosed |
| US-10551566-B2 | Method of preparing an optical connector and optical devices comprising the optical connector prepared thereby | DOW SILICONES CORPORATION (US) | 2020-02-04 | — | — | US | disclosed |
| US-10435585-B2 | Curable composition, method of preparing cured article, and cured article formed thereby | DOW CORNING CORPORATION (US) | 2019-10-08 | — | — | US | disclosed |
| US-10377116-B2 | Method for the production of a polycarbonate laminate | BUNDESDRUCKEREI GMBH (DE) | 2019-08-13 | — | — | US | disclosed |
| US-20090124969-A1 | Protective Coatings for Medical Devices | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-05-14 | — | — | US | disclosed |
| US-7479128-B1 | Protective coatings for medical devices | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2009-01-20 | — | — | US | disclosed |
| US-20090012256-A1 | curing through hydrosilylation; comprising a cured polysiloxane prepolymer containing two or more Si-H groups per molecule obtained by hydrosilylation reaction, and a cyclic siloxane compound with carbon-carbon double bonds; electronics; heat resistance, noncracking, alkali and solvent resistance, optics | ADEKA CORPORATION (JP) | 2009-01-08 | — | — | US | disclosed |
| US-20080058441-A1 | Active Energy Ray-Curable, Organopolysiloxane Resin Composition, Light-Transmitting Component, And Method For Manufacturing The Light-Transmitting Component | DOW TORAY CO., LTD. (JP) | 2008-03-06 | — | — | US | disclosed |
| EP-1852469-A1 | SILICON-CONTAINING CURABLE COMPOSITION AND ITS CURED PRODUCT | Adeka Corporation (JP) | 2007-11-07 | — | — | EP | disclosed |
| EP-1692209-A1 | ACTIVE ENERGY RAY-CURABLE ORGANOPOLYSILOXANE RESIN COMPOSITION, LIGHT-TRANSMITTING COMPONENT, AND METHOD FOR MANUFACTURING THE LIGHT-TRANSMITTING COMPONENT | Dow Corning Toray Co., Ltd. (JP) | 2006-08-23 | — | — | EP | disclosed |
| WO-2005056640-A1 | ACTIVE ENERGY RAY-CURABLE ORGANOPOLYSILOXANE RESIN COMPOSITION, LIGHT-TRANSMITTING COMPONENT, AND METHOD FOR MANUFACTURING THE LIGHT-TRANSMITTING COMPONENT | DOW CORNING TORAY CO., LTD. (JP) | 2005-06-23 | — | — | WO | disclosed |
| EP-1244479-B1 | PROTECTIVE COATINGS FOR MEDICAL DEVICES | BOSTON SCIENT LTD (BB) | 2005-05-11 | — | — | EP | disclosed |
| US-5904504-A | Die attach method and integrated circuit device | FAIRCHILD SEMICONDUCTOR CORP. (US) | 1999-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10435585-B2 | Curable composition, method of preparing cured article, and cured article formed thereby | SETDB1, SETD2, SETD1A | SLC22A6 2171/4885SMN1; SMN2 368/4885MAPT 1258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.